Biotechnology uses living organisms or their parts to develop products or processes with practical applications in various industries, including healthcare. It combines biology, genetics, and other life sciences with engineering and technology to manipulate biological systems for the benefit of humanity.
The use and alteration of biological organisms often lead to ethical discussions, making bioethics an integral part of the use of biotechnology in society and research.
Examples of biotechnologies include genetic engineering, gene therapy, and biopharmaceutical production.
Biotechnology at OsloMet
Researchers at OsloMet use and investigate a variety of biological processes and species to develop new drugs, disease detection tests, and understanding reproductive health.
By utilizing cellular and molecular processes researchers at OsloMet aim to develop or improve:
- Assisted reproductive technology
- Disease detection tests and biomarkers
- Genetically modified organisms and gene-edited organisms
- New drugs
- Vaccines
OsloMet scientists working with biotechnology
Relevant research groups and projects at OsloMet
-
Bacterial components and their effect on energy metabolism in human skeletal muscle cells
Obesity and type 2 diabetes are associated with changes in gut microbiota and disturbed energy metabolism. We hypothesize that there is a crosstalk between gut bacteria and host energy metabolism.
-
Disease and Environmental Exposures
This research group is concerned with diseases and disorders that have a clear correlation to environmental factors both biotic and abiotic in origin.
-
Extracellular vesicles as signaling factors from skeletal muscle cells
Skeletal muscle is an active secretory organ. We are working on the role of extracellular vesicles (EVs) as secreting factors from skeletal muscle, what the EVs contain, and whether they can affect neighboring and distant cells.
-
Exploring the built environment microbiomes of Norwegian nursery schools and nursing homes
We spend much of our lives indoors where we interact with building microbiomes. We have developed methodologies to identify the microbes to which target groups are routinely exposed.
-
Genomics of microbial pathogens
This research group applies genomics to study the evolution, adaptability and resilience of pathogenic viruses and bacteria.
-
Immuno-microbial signatures in colorectal cancer
An overall aim of the project is to define immuno-microbial signatures that can be used for non-invasive detection of colorectal cancer and pre-cancer stages.
-
Lacritin-incorporated nanoparticles as new and improved treatment of dry eye disease
No effective treatment exists for severe forms of dry eye disease (DED). We are developing the protein lacritin, which is found in tears, to become a medicine for dry eye disease.
-
Nanoparticulate drug carriers for delivery of cutting-edge antimicrobials to biofilms
Infections involving biofilms are very difficult to treat effectively. We are developing nanoparticles that can act as carriers for new antibiotics to better treat biofilm-based infections.
-
The ocular microbiota and its role in health and dry eye disease
We are performing in-depth characterizations of the ocular microbiota of dry eye disease sufferers, with the aim of identifying microbial risk profiles for disease development and severity.
-
Smart Development of nano-antibiotics
The project seeks to develop drug formulations of novel antimicrobials, so-called bacteriocins, by applying nanotechnology and artificial intelligence.
-
Male Reproductive Health
This group's research areas are within male reproductive biology, with emphasis on semen quality, testicular cancer, and assisted reproduction. Artificial intelligence is used to develop improved methods for semen analysis.
More about Intelligent Health focus areas
-
Artificial intelligence in healthcare
At OsloMet we work on developing algorithms and models using machine learning tailored towards applications in medical research that will help to solve the challenges in the healthcare sector.
-
Assistive technology
Assistive technology, or in the Nordic context often called welfare technology, refers to tools and services that aim to improve quality of life and wellbeing.
-
Omics technology
OsloMet researchers and research groups apply different omics-technologies to study the molecules of life, how their variation affects their functions, how they are generated and decay.
-
Sensor technology in healthcare
Sensors are devices that react and respond to various stimuli, such as biochemical, electrical, or mechanical signals. OsloMet uses and develops sensors to gather health related data.
-
Intelligent Health focus areas
Through collaborating across disciplines and sectors, we will ensure that research and innovation within health and technology remains user- and problem-oriented.
About Intelligent Health
-
Intelligent Health
This initiative will contribute to develop knowledge and technological solutions that foster improved health and counteract diseases.